
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Yongjia Zhou, Xia Xue, Junwen Luo, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3608-3622
Open Access | Times Cited: 16
Showing 16 citing articles:
CircWDR78 inhibits the development of colorectal cancer by regulating the miR-653-3p/RGS4 axis
Hao Chu, YangPeng Pu, Jiunian Li, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access | Times Cited: 1
Hao Chu, YangPeng Pu, Jiunian Li, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access | Times Cited: 1
Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer
Dongliang Chen, Nuo Chen, Hui Sheng, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
Dongliang Chen, Nuo Chen, Hui Sheng, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
A Brief Survey of Deep Learning-based Models for CircRNA-Protein Binding Sites Prediction
Zhen Shen, Lin Yuan, Wenzheng Bao, et al.
Neurocomputing (2025), pp. 129637-129637
Open Access
Zhen Shen, Lin Yuan, Wenzheng Bao, et al.
Neurocomputing (2025), pp. 129637-129637
Open Access
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion
Hongbo Liu, Haoqi Wang, Wei Gao, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Hongbo Liu, Haoqi Wang, Wei Gao, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
HnRNPR promotes non-small cell lung cancer progression by protecting XB130 mRNA from XRN1- and DIS3L2-mediated degradation
Qinrong Wang, Lingling Liu, Xuanjing Gou, et al.
Cellular Signalling (2025), pp. 111816-111816
Closed Access
Qinrong Wang, Lingling Liu, Xuanjing Gou, et al.
Cellular Signalling (2025), pp. 111816-111816
Closed Access
Regulatory mechanisms of m6A RNA methylation in esophageal cancer: a comprehensive review
Long Wen, Jiang Fu, Zixu Wang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Long Wen, Jiang Fu, Zixu Wang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Recent advances in the reciprocal regulation of m6A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia
Jiawang Yang, Liang Feng, Fenglin Zhang, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108671-108671
Closed Access | Times Cited: 3
Jiawang Yang, Liang Feng, Fenglin Zhang, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108671-108671
Closed Access | Times Cited: 3
Circular RNAs in programmed cell death: Regulation mechanisms and potential clinical applications in cancer: A review
Yudi Gao, Hong Lin, Tiantian Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 135659-135659
Closed Access | Times Cited: 2
Yudi Gao, Hong Lin, Tiantian Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 135659-135659
Closed Access | Times Cited: 2
LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation
Jingwen Yuan, Jiatong Lu, Jie Zhu, et al.
Cancer Letters (2024) Vol. 611, pp. 217398-217398
Closed Access | Times Cited: 2
Jingwen Yuan, Jiatong Lu, Jie Zhu, et al.
Cancer Letters (2024) Vol. 611, pp. 217398-217398
Closed Access | Times Cited: 2
Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6
Yunpeng Li, Aoyu Fan, Yunyan Zhang, et al.
Gene (2024) Vol. 930, pp. 148818-148818
Closed Access | Times Cited: 1
Yunpeng Li, Aoyu Fan, Yunyan Zhang, et al.
Gene (2024) Vol. 930, pp. 148818-148818
Closed Access | Times Cited: 1
EIF4A3-Bound hsa_circ_0006847 Exerts a Tumor-Suppressive Role in Gastric Cancer
Chuanxia Cao, Xinxin Wu, Zhe Li, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 232-244
Closed Access
Chuanxia Cao, Xinxin Wu, Zhe Li, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 232-244
Closed Access
Emerging roles of circular RNAs in nasopharyngeal carcinoma: functions and implications
A Ma, Yuzhong Yang, Lu Lu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
A Ma, Yuzhong Yang, Lu Lu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access
Identification of RNA-binding protein hnRNP C targeting the 3’UTR of the TAP-associated glycoprotein tapasin in melanoma
Yuan Wang, Barbara Seliger
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Yuan Wang, Barbara Seliger
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Hedgehog pathway and cancer: A new area (Review)
Deyi Shen, Yuwei Xia, Yuhan Fu, et al.
Oncology Reports (2024) Vol. 52, Iss. 3
Open Access
Deyi Shen, Yuwei Xia, Yuhan Fu, et al.
Oncology Reports (2024) Vol. 52, Iss. 3
Open Access
Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma
Bo Tian, Yan Bian, Yanan Pang, et al.
Frontiers of Medicine (2024)
Closed Access
Bo Tian, Yan Bian, Yanan Pang, et al.
Frontiers of Medicine (2024)
Closed Access
An Integrated TCN-CrossMHA Model for Predicting circRNA-RBP Binding Sites
Yajing Guo, Xiujuan Lei, Shuyu Li
Interdisciplinary Sciences Computational Life Sciences (2024)
Closed Access
Yajing Guo, Xiujuan Lei, Shuyu Li
Interdisciplinary Sciences Computational Life Sciences (2024)
Closed Access
HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulation
Yuezhou Zhang, Zhao Zhang, Jianzeng Dong, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 1, pp. 83-102
Closed Access
Yuezhou Zhang, Zhao Zhang, Jianzeng Dong, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 1, pp. 83-102
Closed Access